nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—urinary bladder cancer—vaginal cancer	0.36	0.391	CtDrD
Cisplatin—testicular cancer—vaginal cancer	0.286	0.311	CtDrD
Cisplatin—germ cell cancer—vaginal cancer	0.274	0.298	CtDrD
Cisplatin—ATP7B—urethra—vaginal cancer	0.00165	0.0203	CbGeAlD
Cisplatin—SLC31A2—uterine cervix—vaginal cancer	0.00164	0.0202	CbGeAlD
Cisplatin—ATP7B—endometrium—vaginal cancer	0.00162	0.02	CbGeAlD
Cisplatin—SLC31A2—urethra—vaginal cancer	0.00151	0.0186	CbGeAlD
Cisplatin—MT1A—female reproductive system—vaginal cancer	0.0015	0.0185	CbGeAlD
Cisplatin—ATP7B—uterus—vaginal cancer	0.00149	0.0184	CbGeAlD
Cisplatin—SLC31A2—endometrium—vaginal cancer	0.00148	0.0183	CbGeAlD
Cisplatin—ATP7A—epithelium—vaginal cancer	0.00146	0.018	CbGeAlD
Cisplatin—ATP7A—uterine cervix—vaginal cancer	0.00144	0.0178	CbGeAlD
Cisplatin—SLC31A2—mammalian vulva—vaginal cancer	0.00143	0.0177	CbGeAlD
Cisplatin—ATP7B—female reproductive system—vaginal cancer	0.00134	0.0166	CbGeAlD
Cisplatin—ATP7A—urethra—vaginal cancer	0.00133	0.0164	CbGeAlD
Cisplatin—ATP7A—endometrium—vaginal cancer	0.00131	0.0161	CbGeAlD
Cisplatin—SOD1—uterine cervix—vaginal cancer	0.00126	0.0156	CbGeAlD
Cisplatin—ATP7A—mammalian vulva—vaginal cancer	0.00126	0.0156	CbGeAlD
Cisplatin—CYP4A11—vagina—vaginal cancer	0.00125	0.0154	CbGeAlD
Cisplatin—MT2A—female reproductive system—vaginal cancer	0.00125	0.0154	CbGeAlD
Cisplatin—SLC31A1—uterine cervix—vaginal cancer	0.00123	0.0152	CbGeAlD
Cisplatin—SLC31A2—female reproductive system—vaginal cancer	0.00123	0.0151	CbGeAlD
Cisplatin—ATP7B—female gonad—vaginal cancer	0.00122	0.0151	CbGeAlD
Cisplatin—GSTT1—female reproductive system—vaginal cancer	0.00122	0.0151	CbGeAlD
Cisplatin—XDH—uterine cervix—vaginal cancer	0.00122	0.015	CbGeAlD
Cisplatin—ATP7B—vagina—vaginal cancer	0.00121	0.015	CbGeAlD
Cisplatin—SOD1—urethra—vaginal cancer	0.00116	0.0143	CbGeAlD
Cisplatin—SOD1—endometrium—vaginal cancer	0.00114	0.0141	CbGeAlD
Cisplatin—MT2A—female gonad—vaginal cancer	0.00114	0.014	CbGeAlD
Cisplatin—SLC31A1—urethra—vaginal cancer	0.00113	0.014	CbGeAlD
Cisplatin—SLC31A2—female gonad—vaginal cancer	0.00112	0.0138	CbGeAlD
Cisplatin—SLC31A1—endometrium—vaginal cancer	0.00111	0.0137	CbGeAlD
Cisplatin—SLC31A2—vagina—vaginal cancer	0.00111	0.0137	CbGeAlD
Cisplatin—SOD1—mammalian vulva—vaginal cancer	0.00111	0.0136	CbGeAlD
Cisplatin—XDH—endometrium—vaginal cancer	0.0011	0.0136	CbGeAlD
Cisplatin—SLC31A1—mammalian vulva—vaginal cancer	0.00108	0.0133	CbGeAlD
Cisplatin—XDH—mammalian vulva—vaginal cancer	0.00106	0.0131	CbGeAlD
Cisplatin—SOD1—uterus—vaginal cancer	0.00105	0.013	CbGeAlD
Cisplatin—ATP7A—female gonad—vaginal cancer	0.000984	0.0121	CbGeAlD
Cisplatin—ATP7A—vagina—vaginal cancer	0.000978	0.0121	CbGeAlD
Cisplatin—SLC31A1—female reproductive system—vaginal cancer	0.000922	0.0114	CbGeAlD
Cisplatin—XDH—female reproductive system—vaginal cancer	0.000911	0.0112	CbGeAlD
Cisplatin—GSTM1—female reproductive system—vaginal cancer	0.0009	0.0111	CbGeAlD
Cisplatin—ABCC5—uterine cervix—vaginal cancer	0.0009	0.0111	CbGeAlD
Cisplatin—SOD1—female gonad—vaginal cancer	0.000861	0.0106	CbGeAlD
Cisplatin—SOD1—vagina—vaginal cancer	0.000856	0.0106	CbGeAlD
Cisplatin—NQO1—epithelium—vaginal cancer	0.000849	0.0105	CbGeAlD
Cisplatin—NQO1—uterine cervix—vaginal cancer	0.000842	0.0104	CbGeAlD
Cisplatin—SLC31A1—female gonad—vaginal cancer	0.000839	0.0104	CbGeAlD
Cisplatin—SLC31A1—vagina—vaginal cancer	0.000834	0.0103	CbGeAlD
Cisplatin—XDH—vagina—vaginal cancer	0.000824	0.0102	CbGeAlD
Cisplatin—GSTM1—female gonad—vaginal cancer	0.000819	0.0101	CbGeAlD
Cisplatin—MPO—epithelium—vaginal cancer	0.000781	0.00964	CbGeAlD
Cisplatin—NQO1—urethra—vaginal cancer	0.000774	0.00955	CbGeAlD
Cisplatin—NQO1—endometrium—vaginal cancer	0.000762	0.0094	CbGeAlD
Cisplatin—GSTP1—epithelium—vaginal cancer	0.000759	0.00937	CbGeAlD
Cisplatin—GSTP1—uterine cervix—vaginal cancer	0.000753	0.00929	CbGeAlD
Cisplatin—NQO1—mammalian vulva—vaginal cancer	0.000737	0.00909	CbGeAlD
Cisplatin—NQO1—uterus—vaginal cancer	0.000702	0.00866	CbGeAlD
Cisplatin—GSTP1—urethra—vaginal cancer	0.000692	0.00853	CbGeAlD
Cisplatin—GSTP1—endometrium—vaginal cancer	0.000681	0.0084	CbGeAlD
Cisplatin—GSTP1—mammalian vulva—vaginal cancer	0.000658	0.00813	CbGeAlD
Cisplatin—NQO1—female reproductive system—vaginal cancer	0.000631	0.00779	CbGeAlD
Cisplatin—GSTP1—uterus—vaginal cancer	0.000627	0.00774	CbGeAlD
Cisplatin—ABCC5—female gonad—vaginal cancer	0.000614	0.00757	CbGeAlD
Cisplatin—ABCC5—vagina—vaginal cancer	0.00061	0.00753	CbGeAlD
Cisplatin—NQO1—female gonad—vaginal cancer	0.000574	0.00708	CbGeAlD
Cisplatin—NQO1—vagina—vaginal cancer	0.000571	0.00704	CbGeAlD
Cisplatin—ABCC3—female reproductive system—vaginal cancer	0.000566	0.00699	CbGeAlD
Cisplatin—GSTP1—female reproductive system—vaginal cancer	0.000564	0.00696	CbGeAlD
Cisplatin—ABCC3—female gonad—vaginal cancer	0.000515	0.00636	CbGeAlD
Cisplatin—GSTP1—female gonad—vaginal cancer	0.000513	0.00633	CbGeAlD
Cisplatin—GSTP1—vagina—vaginal cancer	0.00051	0.00629	CbGeAlD
Cisplatin—BCHE—uterine cervix—vaginal cancer	0.000456	0.00562	CbGeAlD
Cisplatin—ABCC2—female reproductive system—vaginal cancer	0.000453	0.00558	CbGeAlD
Cisplatin—ABCG2—uterine cervix—vaginal cancer	0.00044	0.00543	CbGeAlD
Cisplatin—BCHE—endometrium—vaginal cancer	0.000412	0.00509	CbGeAlD
Cisplatin—ABCG2—urethra—vaginal cancer	0.000405	0.00499	CbGeAlD
Cisplatin—BCHE—mammalian vulva—vaginal cancer	0.000399	0.00492	CbGeAlD
Cisplatin—ABCG2—endometrium—vaginal cancer	0.000398	0.00492	CbGeAlD
Cisplatin—ABCG2—mammalian vulva—vaginal cancer	0.000385	0.00475	CbGeAlD
Cisplatin—BCHE—uterus—vaginal cancer	0.00038	0.00469	CbGeAlD
Cisplatin—ABCG2—uterus—vaginal cancer	0.000367	0.00453	CbGeAlD
Cisplatin—PTGS2—epithelium—vaginal cancer	0.000354	0.00437	CbGeAlD
Cisplatin—PTGS2—uterine cervix—vaginal cancer	0.000351	0.00433	CbGeAlD
Cisplatin—BCHE—female reproductive system—vaginal cancer	0.000341	0.00421	CbGeAlD
Cisplatin—PTGS2—urethra—vaginal cancer	0.000323	0.00398	CbGeAlD
Cisplatin—PTGS2—endometrium—vaginal cancer	0.000318	0.00392	CbGeAlD
Cisplatin—BCHE—vagina—vaginal cancer	0.000309	0.00381	CbGeAlD
Cisplatin—CYP2B6—female reproductive system—vaginal cancer	0.000304	0.00376	CbGeAlD
Cisplatin—CYP2C9—female reproductive system—vaginal cancer	0.000301	0.00372	CbGeAlD
Cisplatin—ABCG2—female gonad—vaginal cancer	0.0003	0.00371	CbGeAlD
Cisplatin—ABCG2—vagina—vaginal cancer	0.000298	0.00368	CbGeAlD
Cisplatin—PTGS2—uterus—vaginal cancer	0.000293	0.00361	CbGeAlD
Cisplatin—CYP2B6—vagina—vaginal cancer	0.000275	0.0034	CbGeAlD
Cisplatin—PTGS2—female reproductive system—vaginal cancer	0.000263	0.00325	CbGeAlD
Cisplatin—PTGS2—female gonad—vaginal cancer	0.000239	0.00295	CbGeAlD
Cisplatin—PTGS2—vagina—vaginal cancer	0.000238	0.00294	CbGeAlD
Cisplatin—ABCB1—epithelium—vaginal cancer	0.000219	0.0027	CbGeAlD
Cisplatin—ABCB1—uterine cervix—vaginal cancer	0.000217	0.00268	CbGeAlD
Cisplatin—ABCB1—urethra—vaginal cancer	0.0002	0.00246	CbGeAlD
Cisplatin—ABCB1—endometrium—vaginal cancer	0.000196	0.00242	CbGeAlD
Cisplatin—ABCB1—mammalian vulva—vaginal cancer	0.00019	0.00234	CbGeAlD
Cisplatin—ABCB1—uterus—vaginal cancer	0.000181	0.00223	CbGeAlD
Cisplatin—ABCB1—female reproductive system—vaginal cancer	0.000163	0.00201	CbGeAlD
Cisplatin—ABCB1—female gonad—vaginal cancer	0.000148	0.00183	CbGeAlD
Cisplatin—ABCB1—vagina—vaginal cancer	0.000147	0.00182	CbGeAlD
